1Cell.Ai Named Best Healthtech Startup 2026
Recognised for Innovation in Precision Oncology & Patient Impact
Integrated NGS + IHC with WHO-aligned treatment guidance in 10–12 days.
Integrated NGS + IHC with WHO-aligned treatment guidance in 10–12 days.
Dr. Pranad Kshirsagar brings a background in clinical pharmacy and medical communication to precision oncology, with a focus on drug development pipelines, therapeutic mechanisms, biomarkers, and translational science.
Education
Training focused on clinical pharmacology, therapeutic drug management, disease state management, and evidence-based patient care
Experience
Clinical experience in direct patient care, personalized pharmacotherapy management, and participation in clinical trials for vaccine development
Experience
Analyses oncology pipelines, therapeutic mechanisms, and molecular targets to identify scientific & biomarker gaps & explore applications of advanced molecular technologies.
Experience
Works across medical and scientific communication, translational oncology, pipeline analysis, liquid biopsy biomarkers, and lead generation.
No publications found for this author yet.
RJ
publications
SI
publications
NA
publications
BJ
publications
Discover evidence-driven publications, clinical perspectives, and scientific advances from the 1Cell.Ai team.